Amanote Research
Register
Sign In
Is It Ethical to Use Drospirenone-Containing Combined Oral Contraceptives?
Journal of Family Planning and Reproductive Health Care
doi 10.1136/jfprhc-2012-100344
Full Text
Open PDF
Abstract
Available in
full text
Date
July 1, 2012
Authors
Rudiger Pittrof
Publisher
BMJ
Related search
Is It Ethical to Use Drospirenone-Containing Combined Oral Contraceptives?: Authors' Response
Journal of Family Planning and Reproductive Health Care
Prothrombotic Changes in Users of Combined Oral Contraceptives Containing Drospirenone and Cyproterone Acetate
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Drospirenone-Containing Oral Contraceptives Do Not Affect Glucose Regulation and Circulating Corticosterone
Journal of Basic and Clinical Physiology and Pharmacology
Medicine
Drug Discovery
Physiology
Pharmacology
Drospirenone-Containing Oral Contraceptives and Venous Thromboembolism: An Analysis of the FAERS Database
Open Access Journal of Contraception
Yasminelle®: A New Low-Dose Combined Oral Contraceptive Containing Drospirenone
Women's Health
Medicine
Risk of Nonfatal Venous Thromboembolism With Oral Contraceptives Containing Norgestimate or Desogestrel Compared With Oral Contraceptives Containing Levonorgestrel
Journal of Family Planning and Reproductive Health Care
Combined Oral Contraceptives Containing Chlormadinone Acetate and Breast Cancer: Results of a Case-Control Study
British Journal of Cancer
Cancer Research
Oncology
An Overview of the Development of Combined Oral Contraceptives Containing Estradiol: Focus on Estradiol Valerate/Dienogest
Gynecological Endocrinology
Gynecology
Endocrinology
Metabolism
Obstetrics
Diabetes
Noncontraceptive Use of Oral Combined Hormonal Contraceptives in Polycystic Ovary Syndrome—risks Versus Benefits
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
